BridgeMD
Prevention study for Anorexia Nervosa
Official title Metabolic Diet for Relapse Prevention in Anorexia Nervosa
ClinicalTrials.gov ID: NCT05197309
What this study is testing
- What it's testing
- This is an interventional study that will test the safety, tolerability, and efficacy of the Metabolic Diet, which was designed as a treatment for women with anorexia nervosa to remain weight-stable after they have been restored from low weight. Participants will be adult women with anorexia nervosa who have been recently restored to normal weight and adult women with no history of eating disorders.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40, women only. Healthy volunteers may be eligible.
You may be able to join if
- Female
- Age at least 18 and not over 40
- BMI at or above 18.5 kg/m2
- Speaks English
- Medically stable, as cleared by a licensed physician, with vital signs and initial blood draws
You likely can't join if
- Current/lifetime diagnosis of DSM-5 psychotic disorders, bipolar disorders
- Active DSM-5 substance use disorders
- On medications that could affect metabolism \ people are to be free of any medications that could affect metabolism, as discussed with study...
- History of suicide attempt within previous 6 months or acute suicide risk
- Significant current medical illness or metabolic conditions, including diabetes mellitus and pregnancy
- Current/lifetime diagnosis of DSM-5 eating disorders (HC only)
See the full eligibility criteria
- Female
- Age at least 18 and not over 40
- BMI at or above 18.5 kg/m2
- Speaks English
- Medically stable, as cleared by a licensed physician, with vital signs and initial blood draws
- History of DSM-5 diagnosis of Anorexia Nervosa (WR-AN only)
- Weight-restored from underweight BMI (under 18.5 kg/m2) within the past 6 months (WR-AN only)
- Current/lifetime diagnosis of DSM-5 psychotic disorders, bipolar disorders
- Active DSM-5 substance use disorders
- On medications that could affect metabolism \ people are to be free of any medications that could affect metabolism, as discussed with study physician, for 2 weeks prior to primary study visit for glucose function...
- History of suicide attempt within previous 6 months or acute suicide risk
- Significant current medical illness or metabolic conditions, including diabetes mellitus and pregnancy
- Current/lifetime diagnosis of DSM-5 eating disorders (HC only)
- Active DSM-5 depressive disorders (HC only)
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 40 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.